We’re experiencing issues with our datasets and search. We apologise for any inconvenience while we work to fix this.
Following the cardiovascular safety review of all NSAIDs and concerns regarding the risk of hepatotoxicity, the Office of Product Review (OPR) conducted a full safety review of diclofenac.